Help us: Donate
Follow us on:

Iduna Therapeutics


Organization Description


Iduna Therapeutics is developing epigenetic reprogramming therapies that allow the rejuvenation and replacement of tissues that cannot regenerate themselves after injury or degeneration. This could permit regeneration without external tissue or surgery. David Sinclair, Steve Horvath, Juan Carlos Izpisua Belmonte, and Manuel Serrano are contributing to this effort.


David Sinclair, Ph.D.

Harvard Medical School - Professor of Genetics

Steve Horvath, Ph.D.

David Geffen School of Medicine, UCLA